Surprisingly, when the orthotopic LLC model mice treated with LLCvac plus anti-PD-1 and Bev, the anti-tumor efficacy in lung tissue was significantly improved compared to the other three groups (p = 0.0001). The gene discussed is PDCD1; the disease is neoplasm.